Oventus 3D Printed Sleep Apnea Device, O2Vent T, Receives FDA Approval for Release in US

RAPID

Share this Article

oventus logoIf you or someone you know has sleep apnea, then you are probably also very aware that finding a long-term solution can be difficult—but one is much needed. This is a scary condition, and can be life-threatening too. Often accompanied by snoring that is loud enough to wake everyone in the house as well as some of the neighbors, sleep apnea is something for which most everyone wishes there was a magic solution. From sleep clinics to the traditional CPAP mask, treatments often seem available but difficult to keep up with—and are often left behind after a short time due to issues with comfort.

Much of the problem, of course, is that with sleep apnea, patients are tired. They are tired all the time. When you snore, hold your breath, jolt awake, go back to sleep, and then repeat the whole cycle again over and over all night long, actual rest is elusive no matter how long you are in bed. And wearing an uncomfortable mask is often just not something those trying to get some rest can live with long term.

With hopes that the magic of 3D printing can come to the rescue here, Brisbane, Australia’s Oventus Medical has been working on a streamlined, compact solution in the form of their customizable titanium mouth device called the O2Vent. We’ve reported previously on Oventus and their collaboration with Australia’s Commonwealth Scientific and Industrial Research Organisation in bringing this innovative, customized breathing device to market in Australia this year.

deviceThe device is 3D printed in titanium. It’s compact and completely fitted to the individual’s mouth, directing airflow to the back of the throat and preventing obstructions. The Oventus team has created what they call a ‘duckbill,’ a portion of the device that allows for a separate airway pushing airflow to the back of the mouth. The O2Vent begins with a digital design of the patient’s mouth and bite and then is fabricated into a medical grade mouthguard.

Now, those suffering from sleep apnea are even closer to getting many nights of good sleep. Oventus has been granted clearance from the FDA for the O2Vent T, their second generation 3D printed device created by Dr. Chris Hart, a dentist in Brisbane who worked with the company to provide a solution for patients who cannot be treated effectively with existing treatments such as nasal obstructers and who are CPAP1 intolerant.

neil

Neil Anderson, CEO of Oventus

“FDA clearance is consequently an important milestone for us as we strive to bring our innovative product portfolio to the global market to benefit those that suffer from OSA or snore excessively,” said chief executive Neil Anderson.

With this US FDA clearance, now they will be able to bring their sleep apnea device to the US and begin launching it through multiple clinical locations. Beta sites are currently being set up, with a formal launch set for October, said the company in their most recent press release.

The first generation O2Vent was already shown in clinical testing to successfully treat sleep apnea through either eliminating snoring or reducing it significantly. This was demonstrated in all patients in the study, according to Oventus, also stating that the positive results included those people who had nasal obstructions and mainly breathed through their mouths, including when they were asleep.

“The recent clinical data strongly supports its superior performance and clearly demonstrates its effectiveness in treating a range of sleep disorders. It also improves oxygen levels for patients,” said Dr. Hart.

“It means a greater number of patients who are CPAP intolerant or mild to moderate sufferers of sleep apnea now have an alternative treatment option available.”

According to the  US National Institutes of Health there are approximately 12-18 million adults living just in the US alone with sleep apnea, and a stunning 80 percent are not receiving effective care, if any at all. This new device is more than just a great example of what new technology can produce, it truly may be the catalyst for allowing a great many to live longer, happier, well-rested lives.

oventus

The patent is registered in Australia currently, and the product has been on the market there since July, with another patent pending overseas. The O2Vent T is already is registered with the Therapeutic Goods Administration (TGA) in Australia, which the company expects to help pave the way into key European and Asian markets as well. Overall, the company is expecting the titratable version, the O2Vent T, to have similar or even superior results as the jaw position can be more optimized through the titration mechanism.

Find out more at Oventus Medical. The device, previously called ClearWay, is presented in the video below. Discuss further in the 3D Printed Sleep Apnea Device forum over at 3DPB.com.

 

https://youtu.be/oGh46rHV7ow

Share this Article


Recent News

Additive Manufacturing Strategies 2025: Consensus on the Road Ahead for 3D Printing

IperionX Lands $47.1M from DoD for Titanium 3D Printing Powders



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Rapid Fusion Introduces UK’s First Large Format Hybrid 3D Printer for Polymers

Rapid Fusion is set to unveil what it describes as the first UK-built large format hybrid 3D printer, Medusa, at an open day event on February 26 at its Skypark...

ADDiTEC’s AMDROiD X: A Portable DED Metal 3D Printer for Defense

Given the outsized role of the U.S. Department of Defense (DoD) in the additive manufacturing (AM) industry, the Military AM (MILAM) conference in Tampa, Florida, has become a key trade...

UK’s First Homegrown Rocket Launch Nears Reality with £20M Investment

A UK-built rocket launching into space from British soil could finally happen soon. The UK has been working toward this for over a decade. In 2017, the government ramped up...

Featured

Stratasys Secures $120M Investment from Fortissimo Capital Amid Pressure from Bambu Lab

Stratasys Ltd. (NASDAQ: SSYS) has announced a $120 million investment from Fortissimo Capital, an Israeli private equity firm. The deal involves the direct purchase of 11.65 million newly issued shares...